Study Appears to Clear Claritin on Birth Defect
From Times Wire Reports
U.S. researchers have found no link between the allergy medication commonly known as Claritin and a genital birth defect in boys, the Centers for Disease Control and Prevention said.
A study of more than 2,000 boys showed no increased risk for hypospadias when expectant mothers had taken the medication during a period ranging from one month before pregnancy through the first trimester. Hypospadias is a defect in which the urethral opening is not located at the tip of the penis.
